The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

MCRB FINANCIAL STATEMENTS

Seres Therapeutics Inc — balance sheet, income statement and cash flow trends

MCRBSeres Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue1.9 M $Gross Profit1.6 M $ · 83%Operating Income-84 M $ · -4463%Pre-tax Income-22.5 M $ · -1193%Net Income to Owners-22.5 M $ · -1193%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue1.9 M $-68.4%
Gross Profit1.6 M $—
Operating Income-84 M $—
EBITDA-44.3 M $—
Net Income to Owners-22.5 M $-126.1%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets101.6 M
  • Equity34.5 M $34%
  • Current Liabilities20 M $20%
  • Long-term Liabilities47 M $46%

Key Figures

YoY change
Total Assets101.6 M $-29.4%
Total Liabilities67.1 M $-39.5%
Total Equity34.5 M $+4.8%
Cash & ST Investments15.6 M $-65.6%
Total Debt56.6 M $-35.2%
Net Debt41.1 M $-2.4%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-40 M-20 M0-51.3 M $Operating187 K $Investing14.9 M $Financing-36.2 M $Net Change

Key Figures

YoY change
Operating Cash Flow-51.3 M $—
Capital Expenditures37 K $-91.5%
Free Cash Flow-51.3 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on MCRB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.